维普中文期刊产品整合服务
44篇 您的检索式:作者名="Fiveash"
    题名 作者 年代 出处 被引量
1Predictive biomarkers for immune checkpoint blockade and opportunities for combination therapies显示文摘Immune checkpoint blockade therapies(ICBs)are a prominent breakthrough in cancer immunotherapy in recent years(named the 2013“Breakthrough of the Year”by the Science magazine).Thus far,FDA-approved ICBs primarily target immune checkpoints CTLA-4,PD-1,and PD-L1.Notwithstanding their impressive long-term therapeutic benefits,their efficacy is limited to a small subset of cancer patients.In addition,ICBs induce inadvertent immune-related adverse events(irAEs)and can be costly for long-term use.To overcome these limitations,two strategies are actively being pursued:identification of predictive biomarkers for clinical response to ICBs and multi-pronged combination therapies.Biomarkers will allow clinicians to practice a precision medicine approach in ICBs(biomarker-based patient selection)such as treating triple-negative breast cancer patients that exhibit PD-L1 staining of tumor-infiltrating immune cells in1%of the tumor area with nanoparticle albumin-bound(nab)epaclitaxel plus anti-PD-L1 and treating patients of MSI-H or MMR deficient unresectable or metastatic solid tumors with pembrolizumab(anti-PD-1).Importantly,the insights gained from these biomarker studies can guide rational combinatorial strategies such as CDK4/6 inhibitor/fractionated radiotherapy/HDACi in conjunction with ICBs to maximize therapeutic benefits.Further,with the rapid technological advents(e.g.,ATCT-Seq),we predict more reliable biomarkers will be identified,which in turn will inspire more promising combination therapies.Hongxing Shen Eddy Shih-Hsin Yang Marty Conry John Fiveash Carlo Contreras James A.Bonner Lewis Zhichang Shi 2019Genes & Diseases2019,6,3:5
2Initial treatment of efficacy and toxicity显示文摘RADBILL A E FIVEASH J F FALKENBERG E T 2004Cancer2004,,4:1
3Imaging glioma extent with ^131I-TM-601显示文摘Hockaday DC Shen S Fiveash J 2005Nucl Med2005,46,4:1
4Preoperative ra- diation therapy with selective dose escalation to the mar-gin at risk for retroperitoneal sarcoma显示文摘Tzeng CW Fiveash JB Popple RA 2006Cancer2006,107,2:1
5Role of radiation therapy and radiosurgery in gliobastoma multiforme显示文摘Fiveash JB Spencer SA 2003Med Dosim2003,28,4:1
6Imaging glioma extent with ^131I-TM-601 显示文摘Hockaday D C Shen S Fiveash J 2005J Nucl Med2005,46,4:1
7Multimodality treatment of Merkel cell carcinoma: Case series and literature re- view of 1024 cases 显示文摘Medina-Franco H Urist MM Fiveash J 2001Ann Surg Oncol2001,8,3:1
8Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors:a volumetric dose measurement study显示文摘 Shen S Fiveash JB 2006Med Phys2006,33,5:1
9role of radiation therapy and radiosurgery in glioblastoma mulfiforme显示文摘Fiveash JB Spencer SA 2003Cancer J2003,9,3:1
10Treatment of adults with recurrent malignant gliomas显示文摘Nabors LB Fiveash J 2005Expert Rev Neurother2005,5,4:1
11Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases显示文摘Paul W. Sperduto Norbert Kased David Roberge Zhiyuan Xu Ryan Shanley Xianghua Luo Penny K. Sneed Samuel T. Chao Robert J. Weil John Suh Amit Bhatt Ashley W. Jensen Paul D. Brown Helen A. Shih John Kirkpatrick Laurie E. Gaspar John B. Fiveash Veronica Chia 2012International Journal of Radiation Oncology Biology Physics2012,,5:1
12Stereotactic body radiationtherapy for liver metastases and primary hepatocellular carcinoma :normal tissue tolerances and toxicity 显示文摘Sawrie SM Fiveash JB Caudell JJ 2010Journal of the MoffittCancer2010,2,:1
13Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma显示文摘Tzeng CW Fiveash JB Popple RA 2006Cancer2006,107,2:1
14Spencer,Role of radiation therapy and radiosurgery in glioblastoma multiforme显示文摘Fiveash JB Spencer SA 0,,3:1
15Gene expression analysis in radiotherapy patients and C57BL/6 mice as a measure of exposure to ionizing radiation显示文摘Filiano AN Fathallah-Shaykh HM Fiveash J 2011Kadiat Res2011,176,1:1
16Preoperative radiation therapy with selective dose escalation to margin at risk for retroperitoneal sarcoma显示文摘Tzeng CW Fiveash JB Popple RA 0,,02:1
17Preoperative ra- diation therapy with selective dose escalation to the mar- gin at risk for retroperitoneal sarcoma显示文摘Tzeng CW Fiveash JB Popple RA 2006Cancer2006,107,2:1
18Dosimetric effect of respiration gated beam on IMRT delivcry显示文摘Duan J Shen S Fiveash J B 2003Med Phys2003,30,8:1
19Radionecrosis of the inferior occipital lobes with altitudinal visual field loss after gamma knife radiosurgery显示文摘Monheit BE Fiveash JB Girkin CA 2004J Neuro - Ophthalmol2004,24,3:1
20Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor5显示文摘Fiveash IB Gillespie GY Oliver PG et a1 2008Int 1 Radiat Oncol Bioi Phys2008,71,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费